Epsilon Health was founded in 2000

24 years

We are characterized by the constant search for the highest quality and safety for our products
as well as the unquenchable thirst for innovation.

2000

Establishment of the company and commencement of cooperation with Istituto Ganassini

 

2004

Launch of the first probiotic food supplement in Greece, Prolife vials

 

2007

Marketing of the first formulations authorized by Epsilon Health:  Momesalic & Xylanal

 

2011

Start of export activity in Cyprus, Bulgaria and North Macedonia.
Establishment of subsidiaries   Solvis  and  Evolia

2012 – 2013

Launch of the first medical devices, Silben nano & Algoral chewable tabs

 

2015

Launch of the first products of the Effecol & Arichol brands

 

2016 – 2018

Expansion of export activity in Serbia, Moldova, Kosovo and Albania

2020 – 2021

Strengthening Epsilon’s portfolio with Scaball and Sedistress pharmaceuticals

 

2024

Relocation of the company’s headquarters and warehouse to new privately owned premises of 3.000m²

Subsidiaries

SOLVIS DOO
Skopje, North Macedonia

EVOLIA OOD
Sofia, Bulgaria

90+ employees

Administrative
Finance and Logistics
Business Development
Regulatory Affairs

Sales & Marketing Dept.

Covers the whole Balkans' territory
Medical Representatives (50+ reps.)
Direct sales to pharmacies (20+ sales reps.)
Collaboration with local distributors